Press release 📈 Stocks 🌍 United States

NYSE Attracts $500B in Market Cap via Nine Listing Transfers in 2026

The NYSE reports nine major listing transfers in 2026, including AstraZeneca and Kraft Heinz, while highlighting a record-breaking message volume of 1.166 trillion on November 5.

📅 November 12, 2026 🕐 1 min read

4 assets impacted (Stocks). Net bias: 0 Bullish, 1 Bearish, 3 Neutral. Strongest signal: NDAQ ↓ 2/10 (40% confidence).

📊 Affected Assets (4)

NDAQ

Bearish 🤖 40%

📅 Short-term 🌍 US ✨ Inferred

As the exchange losing nine issuers with roughly $500 billion in market cap versus $185 billion flowing the other way, Nasdaq faces reputational and listing-revenue headwinds. However, this is a self-promotional NYSE press release with no Nasdaq financial figures, and listing fees are a small revenue line, so the effect is likely modest.

Catalysts

▼ Nine Nasdaq-to-NYSE transfers year to date, including three former Nasdaq-100 constituents

Risk Factors

▲ $185 billion of market cap also moved from the NYSE to Nasdaq this year

KHC

Neutral 🤖 60%

📅 Short-term 🌍 US · Explicit

The company is named as one of three former Nasdaq-100 constituents that moved its listing to the NYSE this year. A listing venue transfer changes where shares trade but not the company's earnings, dividends or valuation, so no price effect is expected. The NYSE's own data (7.4-9.6% P/E contraction for transfers) is about Nasdaq joiners, not this stock.

AZN

Neutral 🤖 60%

📅 Short-term 🌍 US · Explicit

AstraZeneca is named as a large-cap issuer that transferred from Nasdaq to the NYSE this year. The transfer is administrative; the article cites no change to the company's fundamentals, guidance or valuation, so a days-to-weeks price effect is unlikely.

FITB

Neutral 🤖 60%

📅 Short-term 🌍 US · Explicit

Fifth Third is cited as making the largest bank transfer in history to the NYSE. The article offers no figures on the bank's earnings or balance sheet, and a listing venue change does not alter its fundamentals, so no material price impact is expected.

🧭 Full analysis of these assets

🎯 Key Takeaways

Nine companies transferred from Nasdaq to the NYSE in 2026, including three former Nasdaq-100 constituents.
Nearly $500 billion in market cap moved to the NYSE this year, compared to $185 billion that moved to competitors.
The median market cap of issuers transferring to the NYSE is $15.7 billion, versus $1.4 billion for those moving to competitors.
The NYSE processed a record 1.166 trillion messages on November 5, exceeding the prior peak by 4%.

📝 Executive Summary

The New York Stock Exchange has secured nine listing transfers from competitors this year, representing nearly $500 billion in market capitalization. Notable companies including AstraZeneca, Kraft Heinz, and Fifth Third Bancorp moved to the exchange, which also reported a record 1.166 trillion messages processed on November 5.

❓ FAQ

NDAQ · How bad is losing $500 billion in market cap for Nasdaq?

The article compares it with $185 billion that moved the opposite direction, but gives no figures on what this means for Nasdaq's own revenue.

KHC · Does Kraft Heinz's move to the NYSE change its value?

No. The article describes it as a listing transfer only; nothing about the company's earnings or business changes.

AZN · Will AstraZeneca's share price move because of the listing transfer?

The article gives no fundamental reason for a move; only the trading venue changed.

FITB · Is the Fifth Third listing transfer positive for the stock?

The article frames it as a milestone for the NYSE, not as something that changes Fifth Third's own financial outlook.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article